Literature DB >> 18722353

Acetylation of Sirt2 by p300 attenuates its deacetylase activity.

Younho Han1, Yun-Hye Jin, Yeon-Jin Kim, Bok-Yun Kang, Hyun-Jin Choi, Dae-Won Kim, Chang-Yeol Yeo, Kwang-Youl Lee.   

Abstract

Histone deacetylases (HDACs) are subdivided into three classes--HDAC I, HDAC II, and Sir2. Sirt proteins are mammalian members of the Sir2 family of NAD+ (nicotinamide adenine dinucleotide)-dependent protein deacetylases. The balance between acetylation and deacetylation of histone and non-histone proteins, regulated by protein acetyltransferases and deacetylases, affects the expression of genes involved in a variety of cellular processes. In addition, HDAC1 is acetylated and regulated by p300, a transcriptional co-activator with protein acetyltransferase activity, suggesting that protein acetyltransferases and deacetylases they control the activities of each other. Although the regulation of HDAC1 by p300 is well characterized, the relationship between Sir2 homologs and p300 is not understood. Here, we report that p300 interacts with Sirt2, a member of the Sir2 family, and triggers the acetylation and subsequent down-regulation of the deacetylation activity of Sirt2, and that the acetylation of Sirt2 by p300 relieves the inhibitory effect of Sirt2 on the transcriptional activity of p53. These observations demonstrate that p300 can inactivate Sirt2 by acetylation and that p300 may regulate the activity of p53 indirectly through Sirt2 in addition to its direct modification of p53.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18722353     DOI: 10.1016/j.bbrc.2008.08.042

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation.

Authors:  Yuanjing Liu; Lirong Peng; Edward Seto; Suming Huang; Yi Qiu
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

2.  Molecular cloning, expression and subcellular distribution of an alternative splice variant of the porcine Sirt2 gene.

Authors:  Bingting Liu; Fei Liu; Liang Bai; Yucheng Li; Gongshe Yang
Journal:  Mol Biol Rep       Date:  2009-10-13       Impact factor: 2.316

Review 3.  How histone deacetylases control myelination.

Authors:  Claire Jacob; Frédéric Lebrun-Julien; Ueli Suter
Journal:  Mol Neurobiol       Date:  2011-08-23       Impact factor: 5.590

4.  CobB regulates Escherichia coli chemotaxis by deacetylating the response regulator CheY.

Authors:  Ru Li; Jing Gu; Yuan-Yuan Chen; Chuan-Le Xiao; Li-Wei Wang; Zhi-Ping Zhang; Li-Jun Bi; Hong-Ping Wei; Xu-De Wang; Jiao-Yu Deng; Xian-En Zhang
Journal:  Mol Microbiol       Date:  2010-03-16       Impact factor: 3.501

5.  Sirtuin 2 Isoform 1 Enhances Hepatitis B Virus RNA Transcription and DNA Synthesis through the AKT/GSK-3β/β-Catenin Signaling Pathway.

Authors:  Zahra Zahid Piracha; Hyeonjoong Kwon; Umar Saeed; Jumi Kim; Jaesung Jung; Yong-Joon Chwae; Sun Park; Ho-Joon Shin; Kyongmin Kim
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

Review 6.  The emerging role of acetylation in the regulation of autophagy.

Authors:  Agnes Bánréti; Miklós Sass; Yacine Graba
Journal:  Autophagy       Date:  2013-03-06       Impact factor: 16.016

Review 7.  Acetylation and deacetylation--novel factors in muscle wasting.

Authors:  Nima Alamdari; Zaira Aversa; Estibaliz Castillero; Per-Olof Hasselgren
Journal:  Metabolism       Date:  2012-05-22       Impact factor: 8.694

8.  SIRT2 orchestrates the DNA damage response.

Authors:  Hui Zhang; PamelaSara E Head; David S Yu
Journal:  Cell Cycle       Date:  2016-05-06       Impact factor: 4.534

9.  Sirtuin deacetylases: a new target for melanoma management.

Authors:  Melissa J Wilking; Chandra K Singh; Minakshi Nihal; Mary A Ndiaye; Nihal Ahmad
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 10.  Manipulation of the host protein acetylation network by human immunodeficiency virus type 1.

Authors:  Mark Y Jeng; Ibraheem Ali; Melanie Ott
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-09-02       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.